Non-infectious cholecystopathy secondary to high-dose IL-2 cancer immunotherapy.
Acta Radiol Open
; 4(10): 2058460115579458, 2015 Oct.
Article
em En
| MEDLINE
| ID: mdl-26576289
ABSTRACT
Interleukin-2 (IL-2) associated cholecystopathy is a rare manifestation of IL-2 drug toxicity in the setting of cancer immunotherapy. While the imaging data and clinical presentation can easily mimic acute cholecystitis, the correct diagnosis can be made with the particular clinical history, thus avoiding inappropriate surgical management. As more cancer immunotherapies become standard oncologic treatments, specific immunotherapy-associated side effects are also expected to be encountered more frequently in the future and should be recognized as such. We present a case of IL-2-associated cholecystopathy in the setting of renal cell carcinoma immunotherapy.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Acta Radiol Open
Ano de publicação:
2015
Tipo de documento:
Article
País de afiliação:
Estados Unidos